BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 24938145)

  • 21. Intra-familial phenotypic heterogeneity in adult onset vanishing white matter disease.
    Damon-Perriere N; Menegon P; Olivier A; Boespflug-Tanguy O; Niel F; Creveaux I; Dousset V; Brochet B; Goizet C
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1068-71. PubMed ID: 18845387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vanishing white matter disease.
    van der Knaap MS; Pronk JC; Scheper GC
    Lancet Neurol; 2006 May; 5(5):413-23. PubMed ID: 16632312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukodystrophy Due to
    Shivaram S; Nagappa M; Seshagiri DV; Saini J; Govindaraj P; Sinha S; Bindu PS; Taly AB
    Can J Neurol Sci; 2022 Sep; 49(5):708-712. PubMed ID: 34663487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease.
    Bugiani M; Postma N; Polder E; Dieleman N; Scheffer PG; Sim FJ; van der Knaap MS; Boor I
    Brain; 2013 Jan; 136(Pt 1):209-22. PubMed ID: 23365098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukoencephalopathy with vanishing white matter: from magnetic resonance imaging pattern to five genes.
    Leegwater PA; Pronk JC; van der Knaap MS
    J Child Neurol; 2003 Sep; 18(9):639-45. PubMed ID: 14572143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vanishing white matter disease: an Italian case with A638G mutation in exon 5 of EIF2B2 gene, an unusual early onset and a long course.
    Sambati L; Agati R; Bacci A; Bianchi S; Capellari S
    Neurol Sci; 2013 Jul; 34(7):1235-8. PubMed ID: 22729508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Left hemiparesis as a sign of onset of vanishing white matter disease. Identification of a new mutation].
    Alías Hernández I; Ramos Lizana J; Aguirre Rodríguez J; Aguilera López P; Garzón Cabrera MI; Entrala Bernal C
    An Pediatr (Barc); 2013 Jul; 79(1):46-9. PubMed ID: 23434401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter].
    Pan YX; Wu Y; Niu ZP; Jiang YW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):608-10. PubMed ID: 19829687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Similarities and differences between infantile and early childhood onset vanishing white matter disease.
    Zhou L; Zhang H; Chen N; Zhang Z; Liu M; Dai L; Wang J; Jiang Y; Wu Y
    J Neurol; 2018 Jun; 265(6):1410-1418. PubMed ID: 29663120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An eleven-year history of Vanishing White Matter Disease in an adult patient with no cognitive decline and
    Trevisan L; Grazzini M; Cianflone A; Accogli A; Finocchi C; Capello E; Saitta L; Grandis M; Roccatagliata L; Mandich P
    Neurocase; 2021 Dec; 27(6):452-456. PubMed ID: 34751098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The spectrum of mutations for the diagnosis of vanishing white matter disease.
    Scali O; Di Perri C; Federico A
    Neurol Sci; 2006 Sep; 27(4):271-7. PubMed ID: 16998732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vanishing white matter disease with mutations in EIF2B5 gene.
    Sharma S; Ajij M; Singh V; Aneja S
    Indian J Pediatr; 2015 Jan; 82(1):93-5. PubMed ID: 25230711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Childhood ataxia with CNS hypomyelination/vanishing white matter disease--a common leukodystrophy caused by abnormal control of protein synthesis.
    Schiffmann R; Elroy-Stein O
    Mol Genet Metab; 2006 May; 88(1):7-15. PubMed ID: 16378743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired eukaryotic translation initiation factor 2B activity specifically in oligodendrocytes reproduces the pathology of vanishing white matter disease in mice.
    Lin Y; Pang X; Huang G; Jamison S; Fang J; Harding HP; Ron D; Lin W
    J Neurosci; 2014 Sep; 34(36):12182-91. PubMed ID: 25186761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vanishing white matter disease in a child presenting with ataxia.
    Wilson CJ; Pronk JC; Van der Knaap MS
    J Paediatr Child Health; 2005; 41(1-2):65-7. PubMed ID: 15670229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infantile onset Vanishing White Matter disease associated with a novel EIF2B5 variant, remarkably long life span, severe epilepsy, and hypopituitarism.
    Woody AL; Hsieh DT; McIver HK; Thomas LP; Rohena L
    Am J Med Genet A; 2015 Apr; 167A(4):826-30. PubMed ID: 25758335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vanishing white matter disease associated with progressive macrocephaly.
    Pineda M; R-Palmero A; Baquero M; O'Callaghan M; Aracil A; van der Knaap M; Scheper GC
    Neuropediatrics; 2008 Feb; 39(1):29-32. PubMed ID: 18504679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation.
    La Piana R; Vanderver A; van der Knaap M; Roux L; Tampieri D; Brais B; Bernard G
    Arch Neurol; 2012 Jun; 69(6):765-68. PubMed ID: 22312164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical characteristics of cases with leukoencephalopathy with vanishing white matter].
    Wu Y; Jiang YW; Qin J; Xiao JX; Wang JM; Yang YL; Zhang YH; Chang XZ; Lin Q; Wu XR
    Zhonghua Er Ke Za Zhi; 2007 Feb; 45(2):115-20. PubMed ID: 17456339
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Moon SL; Parker R
    RNA; 2018 Jun; 24(6):841-852. PubMed ID: 29632131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.